Glytec Receives FDA Breakthrough Device Designation for Glucommander Pediatrics, an Insulin Management Technology for Hospitalized Newborns and Infants
The FDA has granted breakthrough device designation to Glytec's Glucommander Pediatrics, an insulin management technology for hospitalized newborns and infants.